Accession Number: | 0001437749-19-018032 |
Date: | 2019-09-04 |
Issuer: | BIOLIFE SOLUTIONS INC (BLFS) |
Original Submission Date: |
DE GREEF RODERICK
C/O BIOLIFE SOLUTIONS, INC.
3303 MONTE VILLA PARKWAY, SUITE 310
BOTHELL, WA 98021
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-09-04 | M | 10,000 | a | $1.64 | 35,859 | direct | ||
COMMON STOCK | 2019-09-04 | S | 10,000 | d | $19.46 | 25,859 | direct | ||
COMMON STOCK | 2019-09-05 | M | 10,000 | a | $1.64 | 35,859 | direct | ||
COMMON STOCK | 2019-09-05 | S | 10,000 | d | $19.99 | 25,859 | direct | ||
COMMON STOCK | 2019-09-06 | M | 10,000 | a | $1.64 | 35,859 | direct | ||
COMMON STOCK | 2019-09-06 | S | 10,000 | d | $19.88 | 25,859 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION | 1.64 | 2019-09-04 | deemed execution date | M | 10,000 (d) | 2019-03-01 | 2021-12-20 | common stock 10,000 | $1.64 | 66,919 | direct | |
EMPLOYEE STOCK OPTION | 1.64 | 2019-09-05 | deemed execution date | M | 10,000 (d) | 2019-03-01 | 2021-12-20 | common stock 10,000 | $1.64 | 56,919 | direct | |
EMPLOYEE STOCK OPTION | 1.64 | 2019-09-06 | deemed execution date | M | 10,000 (d) | 2019-03-01 | 2021-12-20 | common stock 10,000 | $1.64 | 46,919 | direct | |
EMPLOYEE STOCK OPTION | 1.8099 | 2019-09-04 | deemed execution date | 0 ( ) | 2026-05-03 | common stock 104,000 | $1.81 | 104,000 | direct | |||
EMPLOYEE STOCK OPTION | 1.76 | 2019-09-04 | deemed execution date | 0 ( ) | 2026-03-04 | common stock 100,000 | $1.76 | 100,000 | direct |
ID | footnote |
---|---|
f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on june 1, 2018. |
f2 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $18.82 to $20.42 per share, inclusive. the reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
f3 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $19.85 to $20.17 per share, inclusive. the reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
f4 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $19.46 to $20.10 per share, inclusive. the reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
f5 | the stock option vests 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. |
f6 | the stock option vests 25% on the first anniversary of the grant date and thereafter, in 36 equal monthly installments. such options shall continue to vest regardless of whether mr. de greef's service with the company continues |